1.
Bouffioulx E, Arnould, Thonnard JL. Satisfaction with activityand participation and its relationships with body functions,activities, or environmental factors in stroke patients. Arch PhysMed Rehabil 2011; 92: 1404-10.
2.
Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342-4.
3.
Shichita T, Sakaguchi R, Suzuki M, Yoshimura A. Post-ischemicinflammation in the brain. Front Immunol 2012; 3: 132.
4.
Esenwa CC, Elkind MS. Inflammatory risk factors, biomarkersand associated therapy in ischaemic stroke. Nat Rev Neurol 2016;12: 594-04.
5.
FOOD Trial Collaboration. Poor nutritional status on admissionpredicts poor outcomes after stroke: observational data from theFOOD trial. Stroke 2003; 34: 1450-56.
6.
Baird AE. The forgotten lymphocyte: immunity and stroke.Circulation 2006; 113: 2035-6.
7.
Reininger AJ, Bernlochner I, Penz SM, et al. A 2-step mechanismof arterial thrombus formation induced by human atheroscleroticplaques. J Am Coll Cardiol 2010; 55: 1147-58.
8.
Milionis H, Papavasileiou V, Eskandari A, D'Ambrogio-RemillardS, Ntaios G, Michel P. Anemia on admission predicts short- andlong-term outcomes in patients with acute ischemic stroke. Int JStroke 2015; 10: 224-30.
9.
Guo Y, Shi D, Zhang J, et al. The hemoglobin, albumin,lymphocyte, and platelet (HALP) score is a novel significantprognostic factor for patients with metastatic prostate cancerundergoing cytoreductive radical prostatectomy. J Cancer 2019;10: 81-91.
10.
Peng D, Zhang CJ, Tang Q, et al. Prognostic significance of thecombination of preoperative hemoglobin and albumin levels andlymphocyte and platelet counts (HALP) in patients with renal cellcarcinoma after nephrectomy. BMC Urol 2018; 18: 20.
11.
Stroke−1989. Recommendations on stroke prevention, diagnosis,and therapy. Report of the WHO Task Force on Stroke and otherCerebrovascular Disorders. Stroke 1989; 20: 1407-31.
12.
Xu SS, Li S, Xu HX, et al. Haemoglobin, albumin, lymphocyteand platelet predicts postoperative survival in pancreatic cancer.World J Gastroenterol 2020; 26: 828-38
13.
UpToDate. Initial assessment and management of acute strokeAvailable online: https://www.uptodate.com/contents/initial-assessment-and-management-of-acute-stroke. 2023
14.
Brouns R, De Deyn PP. The complexity of neurobiologicalprocesses in acute ischemic stroke. Clin Neurol Neurosurg 2009;111: 483-95.
15.
Kellert L, Martin E, Sykora M, et al. Cerebral oxygen transportfailure?: decreasing hemoglobin and hematocrit levels afterischemic stroke predict poor outcome and mortality: STroke:RelevAnt Impact of hemoGlobin, Hematocrit and Transfusion(STRAIGHT)-an observational study. Stroke 2011; 42: 2832-7.
16.
Chang JY, Lee JS, Kim BJ, et al. Influence of hemoglobinconcentration on stroke recurrence and composite vascularevents. Stroke 2020; 51: 1309-12.
17.
Barlas RS, Honney K, Loke YK, et al. Impact of hemoglobinlevels and anemia on mortality in acute stroke: analysis of UKRegional Registry Data, Systematic Review, and Meta-Analysis. JAm Heart Assoc 2016; 5: e003019.
18.
Eckart A, Struja T, Kutz A, et al. Relationship of nutritional status,inflammation, and serum albumin levels during acute illness: aprospective study. Am J Med 2019; 133: 713-22.e7.
19.
Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as apredictor of ischemic stroke outcome. Stroke 2004; 35: e156-e8.
20.
Kim J, Song TJ, Park JH, et al. Different prognostic value of whiteblood cell subtypes in patients with acute cerebral infarction.Atherosclerosis 2012; 222: 464-7.
21.
Cankar Dal H, Yalnız KY, Tosun D,et al. Platelet-to-lymphocyteratio and mean platelet volume-to-platelet count ratio forpredicting mortality in critical COVID-19 patients. J Health SciMed 2022; 5: 1512-7.
22.
Yang M, Pan Y, Li Z, et al. Platelet count predicts adverse clinicaloutcomes after ischemic stroke or TIA: subgroup analysis ofCNSR II. Front Neurol 2019; 10: 370.